| Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults PJ Connelly, EM Freel, C Perry, J Ewan, RM Touyz, G Currie, C Delles Hypertension, 2019 | 152 | 2019 |
| The importance of Gender to Understand Sex Differences in Cardiovascular Disease PJ Connelly, Z Azizi, P Alipour, C Delles, L Pilote, V Raparelli Canadian Journal of Cardiology, 2021 | 114 | 2021 |
| Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: a GoDarts study PJ Connelly, M Lonergan, E Soto‐Pedre, L Donnelly, K Zhou, ... Diabetes, Obesity and Metabolism 19 (11), 1579-1586, 2017 | 58 | 2017 |
| Sex steroids receptors, hypertension, and vascular ageing PJ Connelly, H Casey, AC Montezano, RM Touyz, C Delles Journal of Human Hypertension, 1-6, 2021 | 46 | 2021 |
| Pharmacokinetics of metformin in patients with gastrointestinal intolerance LJ McCreight, TB Stage, P Connelly, M Lonergan, F Nielsen, C Prehn, ... Diabetes, Obesity and Metabolism 20 (7), 1593-1601, 2018 | 41 | 2018 |
| Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated (ATM), at a locus previously associated with metformin response, cause dysglycaemia and … PJ Connelly, N Smith, R Chadwick, AR Exley, JM Shneerson, ER Pearson Diabetic Medicine 33 (3), 371-375, 2016 | 35 | 2016 |
| recessive mutations in the cancer gene: p61ataxia telangiectasia: p61mutated (atm), at a locus previously associated with metformin response, cause dysglycaemia and insulin … PJ Connelly, N Smith, R Chadwick, AR Exley, JM Shneerson, ER Pearson Diabetic Medicine 31, 44-45, 2014 | 35* | 2014 |
| Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review PJ Connelly, A Clark, RM Touyz, C Delles Journal of Hypertension 39 (2), 223, 2021 | 33 | 2021 |
| Mortality risk remains higher in individuals with type 1 diabetes: A population‐based cohort study (the Ayrshire diabetes follow‐up cohort [ADOC]) A Collier, PJ Connelly, M Hair, L Cameron, S Ghosh, N Waugh Diabetes, Obesity and Metabolism 20 (8), 1965-1971, 2018 | 11 | 2018 |
| Sex and gender aspects in vascular pathophysiology PJ Connelly, KAM Jandeleit-Dahm, C Delles Clinical Science 134 (16), 2203-2207, 2020 | 6 | 2020 |
| Metformin in type 1 diabetes P Connelly, G McKay, JR Petrie Practical Diabetes 32 (5), 186-187a, 2015 | 4 | 2015 |
| Fibroblast Growth Factor 23 (FGF23) is a useful biomarker in the investigation of incidental hypophosphataemia P Connelly, I Galloway, S Gallacher, A Gallagher Society for Endocrinology BES 2018 59, 2018 | 2 | 2018 |
| Life threatening hypoglycaemia associated with illicit benzodiazepines A Naasan, P Connelly, C Brown, R Stevenson, D Carty Society for Endocrinology BES 2019 65, 2019 | | 2019 |
| Degludec insulin in Type 1 diabetes: Effect on glycaemic control, weight and hospital admissions P Connelly, F Lanaghan, D Carson, R Drummond, K Hughes, J Boyle, ... DIABETIC MEDICINE 36, 5-5, 2019 | | 2019 |
| Electronic inpatient diabetes referrals in a university teaching hospital-A glasgow experience P Connelly, S Anwar, C Kueh, S Cleland, N Ghouri Society for Endocrinology BES 2018 59, 2018 | | 2018 |
| Pharmacokinetic study of metformin: Insights into the mechanism of metformin intolerance LJ McCreight, TB Stage, PJ Connelly, M Lonergan, K Brosen, C Prehn, ... DIABETIC MEDICINE 35, 22-22, 2018 | | 2018 |
| The impact of dapagliflozin on HbA1c, systolic blood pressure and weight: a review of dapagliflozin use in a Scottish city CJL Kueh, P Connelly, R Harte, C Smith, JG Boyle Practical Diabetes 34 (4), 129-130, 2017 | | 2017 |
| An audit of the effects of the dose adjustment for normal eating (DAFNE) course on HbA1c and weight PJ Connelly, DM Carty, JG Boyle DIABETIC MEDICINE 34, 11-11, 2017 | | 2017 |
| the management of diabetes in renal inpatients: p186 PJ Connelly, Z Cousland Diabetic Medicine 33, 90, 2016 | | 2016 |
| real world experience with dapagliflozin in a Scottish city: p182 CJ Kueh, P Connelly, C Smith, J Boyle Diabetic Medicine 33, 89, 2016 | | 2016 |
